ISRCTN45347268已完成不适用
Prevention of post-operative atrial fibrillation: pathophysyological characterisation of a pharmacological intervention based on a novel model of non-hypoxic pre-conditioning
Fondo de Desarrollo Científico y Tecnológico (Chile)0 个研究点目标入组 150 人开始时间: 2009年9月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged between 30 - 80 years, either sex
- •2. Scheduled for elective coronary artery bypass graft, valve surgery, or mixed
- •3. In sinus rhythm
排除标准
- •1. Previous heart surgery
- •2. Pre-operative documented history of chronic or paroxysmal AF
- •3. Comorbidities such as congenital or cardiac re-operation
- •4. Advanced hepatic disease (cirrhosis)
- •5. Chronic renal failure (serum creatinine greater than 2.0 mg/dL)
研究者
相似试验
进行中（未招募）
1 期
Prevention of post-operative Atrial Fibrillation by BOTulinum toxin injections into epicardial fat pads around pulmonary veins in patients undergoing cardiac surgeryEUCTR2018-002541-11-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)220
已完成
不适用
Prevention of Postoperative Atrial Fibrillation after Heart Valve Surgery by L-Carnitine: Study Protocol for An Observational Intervention StudyHeart valve diseasesJPRN-UMIN000025737Hokkaido University Hospital; Department of Cardiovascular and Thoracic Surgery16
招募中
2 期
PPOAFVALVEtrialHeart valve diseaseD006349JPRN-jRCTs011190012Shingu Yasushige145
进行中（未招募）
3 期
Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)Cardiac SurgeryNCT04075981Assistance Publique - Hôpitaux de Paris220
尚未招募
Unknown
Post operative occurrence of atrial fibrillation and risk factor analysis among patients undergoing coronary artery bypass grafting in a tertiary care hospital.CTRI/2023/05/052175Dr Pallavi Mishra